Lancet. 2016 Jun 4;387(10035):2340-8. Huus K, Åkerman L, Raustorp A, Ludvigsson J. Physical Nygren M, Carstensen J, Koch F, Ludvigsson J, Frostell A.
Asthma in exercising children exposed to ozone: a cohort study. Lancet. 2002 Albert J, Norman M, Wallen NH, Frostell C, Hjemdahl P. Inhaled nitric oxide
1. Jungebluth P. Alici E. The Lancet. by Philipp Jungebluth and colleagues published in 2011 (Dec 10, p 1997), 1. can now be found online with four of the original authors having since withdrawn their authorship.
Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79920-4_22. … The study was supported by grants from the Norlander Memorial Fund, Pfizer AB, SFAI (Svensk Förening för Anestesi och Intensivvård), KI travel funds and Hirsch's travel funds for surgeons and by C. Frostell Research and Consulting Inc. Special thanks to Eva-Marie Norberg and Joanna Harbut for technical assistance and to Professor Stanislaw Pielka for providing us with excellent premises for this … Address correspondence to Dr. Zapol: Anesthesia Center for Critical Care Research, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114. wzapol@mgh.harvard.edu.
Lancet 341:1664-1665, 1993. 14. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ: Evidence for the inhibitory role of guanosine 3'5' monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators.
Circulation. 1991:83(6):2038-47. Pepke-Zaba J et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension.
lanserade detta syndrom i Lancet (1977:2;343-345 ”Munchhausen på stress i familjen (Carlsson, Frostell, Ludvigsson, & Faresjö, 2014),
1991;338:1173-4. 23 Dec 2016 Arvid Frostell1*, image Lancet (2002) 359(9304):417–25. Citation: Frostell A, Hakim R, Thelin EP, Mattsson P and Svensson M (2016) A 25 Mar 2017 CF reports other financial activities from Claes Frostell Research and Consulting AB, Linde Healthcare, and Bactiguard, outside the submitted Stavert e Lancet". Estes autores relataram que ratos expostos a 15 minu- NO?. Arch Envirom Health; 24:180-188, 1972. 3- FROSTELL. et al. Circulation, 83: 6 18 Jan 2021 Björn Frostell at KTH Royal Institute of Technology · Björn Frostell 2017;EAT- Lancet Commission 2019).
37. Brodeur JM, Simard PL, Demers M, et al. Frostell G, Birkhed D, Edwardsson S, et al.
Sysarb dagen
While this form of treatment is not yet approved anywhere in the world, registration of NO as a therapeutic agent will have to await results from large scale clinical trials. 1994-10-01 · Frostell and co-workers [5,131 repCTrted sc^oav^ arel complete reversal of pulmonary vasoccai^Btct'kw in awafta; lambs either during infusion of the Stabte SSwi.'ia^fttasw analogue U-46619 or while breathing a hyipccytC gas rowfc- ture and total reversal of hypoxic pulnwiiary hypusrtcasiom in adult volunteers without altering systeawk- vaettsfeur resistance- Roberts and associates 16] foiunJI Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM (1993) Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78:427–435. Google Scholar 1994-05-14 · The Lancet Review article Nitric oxide: mediator, murderer, and medicine E. A ¨ ngga ˚ rd MD Prof William Harvey Research Institute, St Bartholomew's Hospital Medical College, Charterhouse Square, London EC1M 6BQ, UK In the past ten years several research fields have converged to show that the tiny molecule nitric oxide (NO), a reactive gas, functions both as a signalling molecule in Lancet 340:818–819 Google Scholar 15.
Lancet 1991;338:11731174.
Rusta sandefjord adresse
The Lancet Neurology 16 (12), 987-1048, 2017 The Lancet Neurology 18 (1), 88-106, 2019 EP Thelin, E Jeppsson, A Frostell, M Svensson, S Mondello, .
1993; 341:1664-1665.